In-vitro and in-vivo anti-inflammatory and antinociceptive effects of the methanol extract of the roots of Morinda officinalis
- 1 May 2005
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 57 (5) , 607-615
Abstract
The anti-inflammatory effects of the methanol extract of the roots of Morinda officinalis (MEMO) (Rubiaceae) were evaluated in-vitro and in-vivo. The effects of MEMO on lipopolysaccharide (LPS)-induced responses in the murine macrophage cell line RAW 264.7 were examined. MEMO potently inhibited the production of nitric oxide (NO), prostaglandin E2 and tumour necrosis factor-α (TNF-α) in LPS-stimulated RAW 264.7 macrophages. Consistent with these results, the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) at the protein level, and of iNOS, COX-2 and TNF-α at the mRNA level, was also inhibited by MEMO in a concentration-dependent manner. Furthermore, MEMO inhibited the nuclear factor kappa B (NF-κB) activation induced by LPS, and this was associated with the prevention of degradation of the inhibitor κB (IκB), and subsequently with attenuated p65 protein in the nucleus. The anti-inflammatory effect of MEMO was examined in rats using the carrageenan-induced oedema model. The antinociceptive effects of MEMO were assessed in mice using the acetic acid-induced abdominal constriction test and the hot-plate test. MEMO (100, 200 mg kg−1 per day, p.o.) exhibited anti-inflammatory and antinociceptive effects in these animal models. Taken together, the data demonstrate that MEMO has anti-inflammatory and antinociceptive activity, inhibiting iNOS, COX-2 and TNF-α expression by down-regulating NF-κB binding activity.Keywords
This publication has 29 references indexed in Scilit:
- Complement-Inhibiting Iridoids from Morinda morindoidesJournal of Natural Products, 2002
- Nuclear Factor κB Is a Molecular Target for Sulforaphane-mediated Anti-inflammatory MechanismsJournal of Biological Chemistry, 2001
- IκB–NF-κB StructuresCell, 1998
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesNew England Journal of Medicine, 1997
- NF-κB: Ten Years AfterCell, 1996
- Mapping of the Inducible IκB Phosphorylation Sites That Signal Its Ubiquitination and Degradation†Molecular and Cellular Biology, 1996
- Control of IκB-α Proteolysis by Site-Specific, Signal-Induced PhosphorylationScience, 1995
- Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κBNature, 1993
- Iridoids. An Updated Review. Part I.Journal of Natural Products, 1990
- The type of analgesic-receptor interaction involved in certain analgesic assaysEuropean Journal of Pharmacology, 1971